Author

C. Gemma

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

S. Ali· 2 shared A. Bekesi· 1 shared A. Belfiore· 1 shared A. J. Nicholls· 1 shared A. Poti· 1 shared A. Singh· 1 shared B. G. Vertessy· 1 shared B. Gyorffy· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

S. Ali

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

VGLL1 drives therapy resistance in estrogen receptor positive breast cancer

C. Gemma, C. Lai, A. Singh, A. Belfiore, N. Portman, H. Z. Milioli, M. Periyasamy, S. Abuelmaaty, A. J. Nicholls, C. Davies, N. R. Patel, G. Simmons, H. Fan, V. Nguyen, L. Magnani, , S. Ali

This study identifies VGLL1 as a driver of resistance to endocrine therapy in ER+ breast cancer and shows that targeting VGLL1/TEAD interaction can inhibit resistant cell growth.

bioRxiv · Nov 29, 2020Cancer Biology

Genome-wide alterations of uracil distribution patterns in human DNA upon chemotherapeutic treatments

H. L. Palinkas, A. Bekesi, G. Rona, L. Pongor, G. Tihanyi, E. Holub, A. Poti, C. Gemma, S. Ali, M. J. Morten, E. Rothenberg, M. Pagano, D. Szuts, B. Gyorffy, B. G. Vertessy

The paper investigates genome-wide uracil distribution changes in human cells after chemotherapy, finding drug-induced shifts toward active genomic regions.

bioRxiv · Mar 4, 2020Biochemistry